Clinics in Laboratory Medicine

Papers
(The median citation count of Clinics in Laboratory Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Copyright25
Preanalytical Challenges of Molecular Microbiology Tests20
Molecular Pathology18
Forthcoming Issues18
Forthcoming Issues18
Forthcoming Issues17
Contents15
Point of Care Testing13
Contributors13
Preface12
Diagnosing Chagas in Pregnancy and Childhood12
Herpes B Virus11
The Mass Spectrometry Revolution in Clinical Microbiology Part 211
Hematopathology Gets Younger10
Digital Health10
Bringing Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging to the Clinics10
Updates in Blood Banking and Transfusion Medicine9
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays8
Rapid Antigen Assays for SARS-CoV-28
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists8
Pediatric Myelodysplastic Syndromes8
Molecular Detection of Oncogenic Gene Rearrangements8
Current Topics in Molecular Diagnostics and Precision Medicine7
Point of Care Molecular Testing7
The Role of Point-of-Care Testing in Specific Populations7
Laboratory Testing and Health Disparities6
Advances in Clinical Cytometry6
Promoting Health Equity Through Effective Laboratory Stewardship Strategies6
Copyright6
Contents6
Digital Imaging and AI Pre-classification in Hematology5
Utility of Single-Gene Testing in Cancer Specimens5
Glycan Imaging Mass Spectrometry5
Taking Center Stage5
Assessing Direct Oral Anticoagulants in the Clinical Laboratory5
Affirmative Healthcare for Transgender and Gender Nonconforming Patients5
Literacy and Language Barriers to Overcome in Laboratory Medicine5
Heparin Induced Thrombocytopenia Testing5
Artificial Intelligence in the Clinical Laboratory5
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)5
Hematology Laboratory in the Digital and Automation Age5
Molecular Pathology of Urothelial Carcinoma4
Point-of-Care Testing for the Diagnosis of Fungal Infections4
Contents4
Point-of-Care Drug Testing4
Contributors4
Contributors4
Molecular Pathology of Ovarian Epithelial Neoplasms4
Update on Lymphoblastic Leukemia/Lymphoma4
Copyright4
Alcohol and Drug Testing in Motor Vehicle Crashes4
Artificial Intelligence in the Clinical Laboratory: Current Practice and Emerging Opportunities4
Contributors4
Breaking Through the Barrier4
Molecular Oncology Diagnostics4
Forthcoming Issues4
Untargeted Mass Spectrometry Applications for Clinical Toxicology4
Contents4
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation4
Replacement of Culture with Molecular Testing for Diagnosis Infectious Diseases4
Red Blood Cell Transfusion3
The Immunophenotypic Profile of Healthy Human Bone Marrow3
Copyright3
The Report Says What?3
Will Antigen Testing Remain Relevant in the Point-of-Care Testing Environment?3
A Concise Synopsis of Current Literature and Guidelines on the Practice of Plasma Transfusion2
Forthcoming Issues2
Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry2
Infant Acute Leukemia2
Contributors2
Gene Rearrangement Detection in Pediatric Leukemia2
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory2
Utility of Flow Cytometry Analysis in the Detection of Nonhematologic Neoplasms2
Is It Possible to Test for Viral Infectiousness?2
Principles and Validation of Bioinformatics Pipeline for Cancer Next-Generation Sequencing2
Copyright2
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-22
Testing Strategies and the Emergence of Designer Benzodiazepines2
Copy Number Analysis in Cancer Diagnostic Testing2
Contributors2
Contributors2
Copyright2
Kidney Tumors1
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms1
Reactive Lymphadenopathies1
Blood Product (Donor) Noninfectious and Infectious Testing and Modification1
The Medical Practice of Molecular Oncology Diagnostics1
Copyright1
HLA Typing by Next-Generation Sequencing1
Interpretation of Bacterial Smears and Cultures Using Artificial Intelligence1
Update on Ovarian Sex Cord–Stromal Tumors1
Significance of SF3B1 Mutations in Myeloid Neoplasms1
Current Trends in Identification and Susceptibility Testing of Mycobacteria1
Contributors1
Clinical Artificial Intelligence1
Transfusion Support of Patients with Myelodysplastic Syndromes1
Copyright1
Copyright1
The Enduring and Expanding Importance of Clinical Cytometry1
Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications1
Regulatory Approach to Point-of-Care/At-Home Testing in the United States1
Advances in Clinical Mass Cytometry1
Transfusion Reactions and Adverse Events1
Antibody Dynamics and Durability in Coronavirus Disease-191
Breath-Based Diagnosis of Infectious Diseases1
Diagnostic Stewardship for Multiplex Respiratory Testing1
Contents1
Hematopathologic Correlates of CAR T-Cell Therapy1
Present and Future Non-Culture-Based Diagnostics: Stewardship Potentials and Considerations1
Hematopathology of the Young1
Artificial Intelligence in the Clinical Laboratory1
Contributors1
Infectious Diseases Diagnostics: From Current Strategies to Future Technologies1
Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia1
Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing – A Laboratory Primer1
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults1
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation1
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology1
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities1
Transfusion Medicine Informatics1
Copyright1
Molecular Pathology of Mature Lymphoid Malignancies0
Hematology Laboratory in the Digital and Automation Age0
Home and Clinical Laboratory Improvement Amendments–Waived Testing for Infectious Diseases—How Do These Fit in the Testing Landscape?0
Contributors0
Advances and Progress in Automated Urine Analyzers0
Opportunities and Drawbacks of Digitalized Morphologic Analysis of Body Fluids0
Forthcoming Issues0
Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance0
Cell-free Nucleic Acids in Cancer0
Pediatric Toxicology0
Best Practice for Clinical Somatic Variant Interpretation and Reporting0
Panel Sequencing for Targeted Therapy Selection in Solid Tumors0
Forthcoming Issues0
Specimen Validity Testing in the Toxicology Laboratory0
Forthcoming Issues0
Childhood Myelodysplastic Syndrome0
Applications of Noninvasive Prenatal Testing for Subchromosomal Copy Number Variations Using Cell-Free DNA0
Racism in Drug Testing0
Forthcoming Issues0
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)0
Diagnosis of Tick-Borne Diseases in New England0
Recent Advances in Therapeutic Drug Monitoring of Antineoplastic and Antimicrobial Agents in Children0
Molecular Pathology of Prostate Cancer0
Molecular Biomarkers of Response to Cancer Immunotherapy0
Copyright0
Metaplastic Breast Carcinoma Revisited; Subtypes Determine Outcomes0
Access Barriers in Testing for Sexually Transmitted Infections across Gender and Sexual Identities0
Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders0
How to Design and Validate a Clinical Flow Cytometry Assay0
Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results0
Detecting Xylazine0
Advances in Clinical Toxicology Testing0
Point-of-Care Testing for Sexually Transmitted Infections0
Alternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies0
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-20
Advances in Chromatography-Free and Ambient Ionization Mass Spectrometry Techniques Toward Clinical Toxicology Testing0
Advances in Bone Marrow Evaluation0
Molecular Diagnostics for Invasive Molds: From Lab to Bedside0
Contributors0
Forthcoming Issues0
Contributors0
Advances in Hematology Analyzers Technology0
The Evolving Role of Molecular Diagnostics in Pathology0
Copyright0
Implementation of Mass Spectrometry Imaging in Pathology0
Contents0
Myelodysplastic Syndromes0
Contributors0
Update on Acute Leukemias of Ambiguous Lineage0
Antigen Loss after Targeted Immunotherapy in Hematological Malignancies0
Flow Cytometric Assessment of Malignant Hematologic Disorders0
Artificial Intelligence Applications in Clinical Chemistry0
Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes0
History, Advances, and Challenges of Sickle Cell Disease Treatment0
Routine Coagulation0
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States0
The Advancement of Infectious Diseases Diagnostics0
Morphologic Characteristics of Myelodysplastic Syndromes0
Contents0
Diagnostics Stewardship in Molecular Microbiology: From at-home Testing to Next-Generation Sequencing0
Clinical Cytometry for Platelets and Platelet Disorders0
A New Landscape of Testing and Therapeutics in Metastatic Breast Cancer0
Transfusion Blood Bank (Recipient) Testing0
Working with the Electronic Health Record and Laboratory Information System to Maximize Ordering and Reporting of Molecular Microbiology Results0
Applications of Flow Cytometry in Diagnosis and Evaluation of Red Blood Cell Disorders0
Platelet Transfusion0
Molecular Pathology of Gliomas0
Contents0
Screening of Myelodysplastic Syndromes Using Research Parameters of Complete Blood Count0
Copyright0
Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification0
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP530
Germline Predisposition to Myeloid Neoplasms0
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders0
Addressing Health Disparities in Clinical Pathology and Laboratory Medicine0
Blood Group Genotyping0
Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting0
Electronic Health Record Optimization for Artificial Intelligence0
Pan-Cancer Molecular Biomarkers0
Forthcoming Issues0
Molecular Alterations in Pediatric Solid Tumors0
Practical Challenges of Point-of-Care Testing0
Using Artificial Intelligence to Better Predict and Develop Biomarkers0
Specimen Considerations in Molecular Oncology Testing0
Covid-19 Molecular Testing and Clinical Correlates0
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility0
Mass Spectrometry and Microbial Diagnostics in the Clinical Laboratory0
Advances in Myelodysplastic Syndromes0
Current Topics in Molecular Diagnostics and Precision Medicine0
Molecular Methods0
Copyright0
Forthcoming Issues0
Whole Blood Transfusion0
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management0
Candida auris Diagnostics0
Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States0
Special Considerations in the Molecular Diagnostics of Pediatric Neoplasms0
A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic0
Detection of Fentanyl and Fentanyl Analogs0
Advances in Hemoglobinopathies and Thalassemia Evaluation0
SARS-CoV-2 Molecular Diagnostics in China0
Donor Screening and Deferral0
Steps Forward to a Fair and Inclusive Blood Supply0
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests0
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe0
Forthcoming Issues0
Contents0
Molecular Pathology of Myeloid Neoplasms0
The Mass Spectrometry Revolution in Clinical Microbiology Part 10
Update in Transfusion Medicine Education0
Reflexive Drug Testing Strategies for Efficient Utilization of Resources and Better Interpretation0
Beyond LC-MS: The Next Frontier in Clinical Mass Spectrometry0
When Tissue Is the Issue0
Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization0
Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses0
Practical Considerations for Implementing Targeted Mass Spectrometry for Urine Drug Testing in Clinical Laboratories0
Opportunities and Challenges with Artificial Intelligence in Genomics0
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia0
Forthcoming Issues0
Contents0
Practical Considerations for Implementing Immunoassays for Urine Drug Testing in Clinical Laboratories0
Interpreting Toxicology Results in Perinatal and Newborn Specimens0
Advances in Acute Myeloid Leukemia Classification, Prognostication and Monitoring by Flow Cytometry0
Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes0
Precision Medicine Using Pharmacogenomic Panel-Testing0
Automation in Flow Cytometry0
A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma0
Molecular Pathology of Gastroesophageal Cancer0
Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis0
0.10867309570312